JFL LIFE SCIENCES LIMITED Share Price

NSE: JFLLIFE

S Cap

₹ 10.15

-₹0.40 (-3.79%)

Last updated 02 Sep, 2026, 14:30 IST

JFL LIFE SCIENCES LIMITED Share Price Today

As of 3 Sep 2026, JFL LIFE SCIENCES LIMITED share price is ₹10.15. The stock opened at ₹10.50, compared to its previous close of ₹10.55. During today's trading session, JFL LIFE SCIENCES LIMITED share price moved in the range of ₹10.15 to ₹10.50, with an average price of ₹10.32 for the day. Looking at its last 52-week, the stock has touched a low of ₹8.55 and a high of ₹15.40. On the performance front, JFL LIFE SCIENCES LIMITED share price has declined by 2.87% over the last six months and is down 29.27% on a year-on-year basis.

₹10.15

3.79% down today

₹10.50

1D LOW

1D HIGH

Stock Performance

UnderperformingUnderperforming Nifty by 23.81 % in last 1 yr

JFL LIFE SCIENCES LIMITED Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹3,54,895-₹1,45,105 (-29.02%)

3 Year

₹1,08,209-₹3,91,791 (-78.36%)

5 Year

₹1,14,819-₹3,85,181 (-77.04%)

₹10.05₹11.05

Circuit Low

Circuit High

₹8.55₹15.40

52-Week Low

52-Week High

Circuit

₹10.05

₹11.05

52-week

₹8.55

₹15.40

About JFL LIFE SCIENCES LIMITED

ISIN

INE0LA901015

Sector Market Cap

₹ 34.81 Cr

JFL Life Sciences Limited is an India-based pharmaceutical company. The Company's business segment comprises manufacturing and selling of pharmaceutical products. It is engaged in domestic as well as international business. The Company's main product categories include Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet, and capsules (General) and Oral Rehydration Solutions (ORS). Its beta-lactam dry powder injection products include Ampicillin Injection, Cefotaxime Sodium Injection, Cefazoline Sodium Injection, meropenem injection, amoxicillin injection, cefTAZidime injection, flucloxacillin injection, among others. Its beta-lactam tablets and capsule products include Cefadroxil Tablets, Cefadroxil Capsules, among others. Its general tablet and capsule products include Azithromycin Tablets, Iburofen Tablets, Ciprofloxacin Tablets, Ofloxacin Tablets, Paracetamol Tablets, among others. These products are offered in different milligrams (mg).

JFL LIFE SCIENCES LIMITED Financial Highlights

Revenue: JFL LIFE SCIENCES LIMITED reported revenue of ₹131.45 crore in FY26 vs ₹82.05 crore in FY25. It showed an increase of 60.21% on a yearly basis.
Operating Profit: JFL LIFE SCIENCES LIMITED reported an operating profit of ₹8.60 crore in FY26 vs ₹6.14 crore in FY25. It showed an increase of 40.07% on a year-on-year basis.
Net Profit: JFL LIFE SCIENCES LIMITED reported a net profit of ₹6.40 crore in FY26 vs ₹4.16 crore in FY25. It showed an increase of 53.85% on a yearly basis.

JFL LIFE SCIENCES LIMITED Quarterly Result Highlights

JFL LIFE SCIENCES LIMITED reported revenue of ₹11.12 crore in Jun 2026, compared with ₹63.09 crore in Mar 2026, representing a decrease of 82.37% on a quarter-on-quarter (QoQ) basis.
JFL LIFE SCIENCES LIMITED reported an operating profit of ₹1.49 crore in Jun 2026, compared with ₹2.25 crore in Mar 2026, representing a decrease of 33.78% on a quarter-on-quarter (QoQ) basis.
JFL LIFE SCIENCES LIMITED reported a profit of ₹1.11 crore in Jun 2026, compared with ₹1.66 crore in Mar 2026, reflecting a decrease of 33.13% on a QoQ basis.
The earnings per share (EPS) of JFL LIFE SCIENCES LIMITED stood at ₹1.26 during Jun 2026.

Know more

Promoters

67.47%

FII

0.00%

Other DII

0.00%

Retail and other

32.53%

Mutual funds

0.00%

Foreign institutions - FII

FII shareholding by period
Sep 2025	0.00%
Dec 2025	0.00%
Mar 2026	0.00%
Jun 2026	0.00%

Mkt Cap Cr

34.81

P/E

4.95

P/B

0.73

ROE

13.96%

D/E

0.47

ROCE

15.84%

Div. Yield

0.00%

EPS(TTM)

1.94

Turnover

1.23

EV/EBITDA

4.61

Net Margin

0.00%

Op. Margin

0.00%

ROA

6.36%

Quick Ratio

0.00

Curr. Ratio

2.40

Mkt Cap Cr

34.81

P/E

4.95

P/B

0.73

ROE

13.96%

D/E

0.47

ROCE

15.84%

Div. Yield

0.00%

EPS(TTM)

1.94

Turnover

1.23

EV/EBITDA

4.61

Net Margin

0.00%

Op. Margin

0.00%

ROA

6.36%

Quick Ratio

0.00

Curr. Ratio

2.40

Based on fundamentals, this stock's

Performance

Very Poor

JFL Life has not beaten FD return of 7%

Valuation

Fairly Valued

JFL Life appears to be fairly valued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,63,180.00	38.28	5.55	13.74%	0.61	17.33%	93.24	0.83%	0.48	10.90
Divis Laboratories	2,43,302.00	83.79	14.62	15.32%	0.00	19.56%	629.49	0.32%	0.55	98.19
Torrent Pharmaceuticals	1,88,623.00	88.29	22.64	25.49%	1.69	13.85%	222.76	0.68%	0.49	58.70
Zydus Lifesciences	1,16,114.00	25.00	4.24	18.59%	0.31	17.35%	237.30	0.09%	0.33	35.38
Cipla	1,14,554.00	34.02	3.32	11.27%	0.00	14.95%	423.36	0.92%	0.45	43.52
Laurus Labs	1,00,498.00	92.32	18.99	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Lupin	98,312.20	17.73	4.38	23.76%	0.04	24.88%	659.00	0.84%	0.57	129.18
Dr. Reddy's Laboratories	97,741.00	30.44	2.55	11.07%	0.18	12.54%	377.95	0.69%	0.41	38.68
Mankind Pharma	97,467.00	47.14	5.98	11.74%	0.34	13.13%	397.02	0.04%	0.44	49.37
Aurobindo Pharma	96,836.10	25.68	2.52	9.25%	0.19	11.76%	394.82	0.24%	0.38	41.58

JFL LIFE SCIENCES LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹82.04	₹46.55	₹42.83	₹33.59
Other Income	₹0.01	₹0.51	₹1.64	₹0.89
Total Revenue	₹82.05	₹47.06	₹44.47	₹34.48
Total Expenses	₹75.92	₹43.27	₹40.75	₹30.68
Profit Before Tax	₹6.14	₹3.79	₹3.72	₹3.80
Tax	₹1.98	₹0.49	₹0.91	₹0.99
Profit After Tax	₹4.16	₹3.30	₹2.81	₹2.81
EPS - Basic	₹1.26	₹1.00	₹2.90	₹4.12
EPS - Diluted	₹1.26	₹1.00	₹2.90	₹4.12

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹6.13	₹3.80	₹3.72	₹3.80
Income before WC changes	₹8.20	₹5.05	₹5.57	₹6.24
Change in Assets	-₹16.30	-₹1.83	-₹2.15	-₹18.88
Change in Liabilities	₹5.59	₹5.19	-₹11.49	₹14.83
Change in WC	-₹10.71	₹3.36	-₹13.64	-₹4.05
Cash flow from Operations	-₹3.53	₹8.36	-₹9.07	₹2.32
Cash flow from Investing	-₹0.01	-₹6.07	₹0.87	-₹0.71
Cash flow from Financing	₹3.54	-₹2.31	₹8.07	-₹1.46
Total Cash Flow	₹0.00	-₹0.03	-₹0.13	₹0.15
Cash (Start of the year)	₹0.03	₹0.06	₹0.19	₹0.04
Cash (End of the year)	₹0.03	₹0.03	₹0.06	₹0.19

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹12.41	₹13.11	₹7.93	₹8.96
Current Assets	₹59.50	₹43.60	₹41.13	₹39.30
Total Assets	₹71.91	₹56.71	₹49.06	₹48.26
Current Liabilities	₹31.62	₹20.63	₹15.22	₹28.38
Net Current Asset	₹27.88	₹22.97	₹25.91	₹10.92
Non-Current Liabilities	₹0.84	₹0.51	₹1.57	₹8.59
Equity Capital	₹39.46	₹35.58	₹32.27	₹11.29
Total Equity & Liabilities	₹71.91	₹56.71	₹49.06	₹48.26